Recent clinical advances in cancer immunotherapy, the product of many years of basic and translational research, are harbringers of a new age of cancer treatment where immunotherapy will play a major role in the management and control of cancer. The Koch Institute (KI) for Integrative Cancer Research at MIT has held a summer symposium focused on key topics in cancer research for the past 12 years, and this year's symposium, in timely fashion, focused on Cancer Immunology and Immunotherapy, covering recent preclinical and clinical advances in this field. In keeping with the interdisciplinary biology-engineering fusion of the KI, this day-long meeting included talks from frontline clinical researchers, immunologists focused on fundamentals of cancer immunobiology, and engineers focused on the development of new therapeutic and diagnostic technologies for assessing and treating cancer.
- Received August 7, 2013.
- Accepted August 12, 2013.
- Copyright © 2013, American Association for Cancer Research.